Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
life sciences
4
×
national blog main
national top stories
4
×
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
checkpoint inhibitors
clinical trials
fda
american society of clinical oncology (asco)
amy heimberer
anti-inflammatory drugs
arcturus therapeutics
arena pharmaceuticals
avrobio
barrow neurological institute
ben and catherine ivy foundation
biobucks
What
cancer
4
×
drug
4
×
medicine
tiny
adding
ahead
alzheimer's
ambien
american
annual
asco
attendees
attention
bad
bets
biotech
boost
brain
camp’s
case
cash
chicago
city
clinical
combinations
community’s
days
disease
doses
eisai
expanding
expensive
failed
far
fda
fight
flags
focus
fortune
gilead
Language
unset
Current search:
drug
×
biotech
×
" life sciences "
×
" national top stories "
×
cancer
×
" seattle blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
